Autonomix Medical (AMIX) Long-Term Debt Issuances (2023 - 2024)

Autonomix Medical's (AMIX) quarterly Long-Term Debt Issuances came in at $2.0 million in Q1 2024, up 21.21% on a QoQ basis from $1.6 million in Q4 2023.

Autonomix Medical (AMIX) Long-Term Debt Issuances (2023 - 2024) Analysis & Trends

Autonomix Medical (AMIX) has 2 years of Long-Term Debt Issuances data on file, last reported at $2.0 million in Q1 2024.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $2.0 million in Q1 2024; TTM through Mar 2025 was $3.6 million, a 8.75% decrease from a year earlier, with the FY2024 full-year figure at $2.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q1 2024 stood at $2.0 million, up from $1.6 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for AMIX reached as high as $2.0 million in Q1 2024 and fell as low as $350000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 19.86 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 11.71 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 1.15 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Autonomix Medical 1.03 Mn 1.03 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 2.00 Mn
Mar 31, 2024 2.00 Mn
Dec 31, 2023 1.65 Mn
Dec 31, 2023 1.65 Mn
Sep 30, 2023 350,000.00
Sep 30, 2023 350,000.00